Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006, 150(2):267-269 | DOI: 10.5507/bp.2006.039

EARLY DIAGNOSIS OF DIC DEVELOPMENT INTO THE OVERT PHASE

Jan Urgea, Jan Strojilb
a 2nd Internal Clinic, University Hospital Olomouc, Czech Republic
b Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic

Background: Disseminated intravascular coagulation (DIC) is a syndrome characterized by over-activation of intravascular coagulation, accompanied by consumption of coagulation factors. It is a pathologic systemic inflammatory response accompanied by release of coagulatory substances into the circulation.

Aim: The aim of this paper is to emphasize the importance of early the early diagnosis of DIC and to present a case report of a successful early diagnosis and treatment.

Method: A case report giving a detailed account of clinical and laboratory presentation of a case of DIC in a patient with sepsis. Relevant laboratory results and other tests are presented, treatment is described in detail.

Conclusions: DIC remains an important and potentially life-threatening complication of severe disease and states. Early diagnosis is vital for the success of treatment, and in severely ill patients, the possibility of DIC should always be kept in mind in order to detect early signs and initiate treatment as soon as possible.

Keywords: Disseminated intravascular coagulation, Early diagnosis, Treatment

Received: September 22, 2006; Accepted: November 9, 2006; Published: December 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Urge, J., & Strojil, J. (2006). EARLY DIAGNOSIS OF DIC DEVELOPMENT INTO THE OVERT PHASE. Biomedical papers, 150(2), 267-269. doi: 10.5507/bp.2006.039
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Tailor FB Jr, Tob CH, Holte K, Wada H, Levi M. Towards a definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation. Thrombosis and Haemostasis 2000; 86:1327-1330. Go to original source...
    2. Penka M et al. Diseminovaná intravaskulární koagulace (DIC). Grada Publishing, 2003:25-26.
    3. Bull BS, Bull MH. Disseminated intravascular inflammation as the inflammatory countepart to disseminated intravascular coagulation. Proc. Ntl. Acad. Sci 1994; 91:8190-8194. Go to original source...
    4. Inthorn D, Hoffman JN Gerinnungsstoerungen bei Sepsis. Haemostaseologie 2000; 20:117-123. Go to original source...
    5. Krč I, Krčová V, Slavík L, Konečný M, Divoká M, Ježáková J, Inflammatory bowel disease and thrombophilia, Biomed. Papers 2003, 147, Suppl. 1:61.
    6. Levi, M.,De Jonge, Van der Poll, T., et al.Disseminated Intravascular Coagulation. Thrombosis and Haemostasis, 1999; 82(2):695- 705. Go to original source... Go to PubMed...
    7. Sallah,S.,Wan, JY., Ngguyen, NP., et al. Disseminated Intravascular Coagulation in Solid Tumors: Clinical and pathologic Study. Thrombosis and Haemostasis, 2001; 86:823-833. Go to original source...
    8. Bick RL, Disseminated Intravascular Coagulation. A Rewiew of Etiology , Pathophysiology, Diagnosis and Management: Guidelines for Care. Clinic Appl Thrombosis/Hemostasis 2002; 8(1):1-31. Go to original source...
    9. Bick RL, Disseminated Intravascular Coagulation. Objektive Laboratory Diagnostic Kriteria and Guidelines for Management (1994). Clinics in Laboratory Medicine 1994; 14(4):729-769. Go to original source...
    10. Carey MJ, Rodgers GM Disseminated Intravascular Coagulation: Clinical and Laboratopry Aspects. American Journal of Hematology 1998; 59:65-73. Go to original source... Go to PubMed...
    11. Dhainaut J, Yan S, Joyce D, Pettilä V, Basson B, Brandt J, Sundin D, Levi M. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004; 2(11):1924-33. Go to original source... Go to PubMed...

    Return to the content